Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Central Nervous System Lymphoma”

660 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 660 results

Testing effectiveness (Phase 2)Ended earlyNCT02420795
What this trial is testing

Akt/ERK Inhibitor ONC201 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Central Nervous System LymphomaGastric Mantle Cell LymphomaRecurrent Mantle Cell Lymphoma+4 more
M.D. Anderson Cancer Center 16
Testing effectiveness (Phase 2)Study completedNCT00596154
What this trial is testing

Rituximab, Methotrexate, Procarbazine and Vincristine Followed by High-dose Chemotherapy With Autologous Stem-cell Rescue in Newly-diagnosed Primary CNS Lymphoma

Who this might be right for
CNS LymphomaCNS Brain CancerNon-Hodgkin's Lymphoma
Memorial Sloan Kettering Cancer Center 33
Testing effectiveness (Phase 2)Ended earlyNCT01065805
What this trial is testing

Demonstrate the Safety and Preliminary Efficacy of 18F-FLT in Patients With Solid Tumours or Lymphoma

Who this might be right for
Brain CancerCancerSolid Tumor+1 more
AHS Cancer Control Alberta 94
Post-approval studies (Phase 4)Study completedNCT00576472
What this trial is testing

Learning Impairments Among Survivors of Childhood Cancer

Who this might be right for
Acute Lymphoblastic LeukemiaBrain Tumors
St. Jude Children's Research Hospital 469
Not applicableActive Not RecruitingNCT06817122
What this trial is testing

The "Let's Talk Tech" Tool to Support Decision Making About Technology Use

Who this might be right for
Dementia, MildMild Cognitive Impairment (MCI)
University of Washington 240
Not applicableUnknownNCT04826146
What this trial is testing

Pediatric Validation of CONOX Monitor During Surgery

Who this might be right for
AnesthesiaAnesthesia AwarenessNociceptive Pain+3 more
Patricio Gonzalez Pizarro 65
Not applicableActive Not RecruitingNCT06649591
What this trial is testing

Expert Consensus and Artificial Intelligence in Medical Decision Making in Patients with Malignant Brain Tumors

Who this might be right for
Malignant Brain Tumors
Tufts Medical Center 225
Large-scale testing (Phase 3)UnknownNCT00020865
What this trial is testing

Levofloxacin Compared With Cefepime in Treating Cancer Patients With Fever and Neutropenia

Who this might be right for
Fever, Sweats, and Hot FlashesInfectionLeukemia+3 more
Jonsson Comprehensive Cancer Center
Not applicableStudy completedNCT02505165
What this trial is testing

Illness Management and Parental Adjustment to Cancer Treatment

Who this might be right for
Solid TumorLeukemiaLymphoma+1 more
Children's Hospital Medical Center, Cincinnati 279
Early research (Phase 1)Study completedNCT00049400
What this trial is testing

S0355 Ixabepilone in Treating Patients With Advanced Solid Tumors or Lymphomas and Liver Dysfunction

Who this might be right for
LymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific
SWOG Cancer Research Network 78
Early research (Phase 1)Ended earlyNCT00087009
What this trial is testing

Beta-Glucan and Rituximab in Treating Young Patients With Relapsed or Progressive Lymphoma or Leukemia, or Lymphoproliferative Disorder Related to Donor Stem Cell Transplantation

Who this might be right for
LeukemiaLymphomaLymphoproliferative Disorder
Memorial Sloan Kettering Cancer Center 3
Not applicableLooking for participantsNCT06691698
What this trial is testing

Evaluation of CO-OP for Adolescents With Mild Intellectual Disability

Who this might be right for
Intellectual Disability, Mild
Örebro University, Sweden 60
Testing effectiveness (Phase 2)Study completedNCT02542514
What this trial is testing

Study of Ibrutinib in Patients With Relapsed or Refractory Primary Central Nervous Lymphoma or Intraocular Lymphoma

Who this might be right for
Primary Central Nervous LymphomaIntraocular Lymphoma
The Lymphoma Academic Research Organisation 52
Not applicableStudy completedNCT05637801
What this trial is testing

A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (HOPE Study)

Who this might be right for
Alzheimer DiseaseAlzheimer Disease 1Alzheimer Disease 2+32 more
Cognito Therapeutics, Inc. 673
Testing effectiveness (Phase 2)Study completedNCT00045539
What this trial is testing

Methotrexate and Thiotepa in Treating Patients With Newly Diagnosed Primary CNS Lymphoma

Who this might be right for
Lymphoma
New Approaches to Brain Tumor Therapy Consortium
Post-approval studies (Phase 4)Looking for participantsNCT05518383
What this trial is testing

B-cell Mature Non-Hodgkin's Lymphoma Treatment Protocol in Children and Adolescents 2021

Who this might be right for
Non-hodgkin Lymphoma,B CellBurkitt LymphomaPrimary Mediastinal Lymphoma+2 more
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 300
Large-scale testing (Phase 3)Looking for participantsNCT07083154
What this trial is testing

Mazdutide in Type 2 Diabetes With Early-Stage Cognitive Impairment (LIGHT-COG Study)

Who this might be right for
Dementia, MildMild Cognitive ImpairmentType 2 Diabetes
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 420
Not applicableStudy completedNCT05860127
What this trial is testing

Cognitive Stimulation Therapy for Dementia: A Two-Armed Pragmatic Trial

Who this might be right for
DementiaCognitive Impairment, MildDementia, Vascular+6 more
University of Massachusetts, Amherst 133
Not applicableLooking for participantsNCT07074470
What this trial is testing

Combination Regimen of Teniposide, PD-1 Monoclonal Antibody and Selinixor for Patients With Relapsed or Refractory PCNSL

Who this might be right for
Primary Central Nervous System Lymphoma (PCNSL)
The First Affiliated Hospital of Soochow University 40
Early research (Phase 1)Active Not RecruitingNCT04443829
What this trial is testing

Immunotherapy Using CAR T-cells to Target CD19 for Relapsed/Refractory CD19+ Primary CNS Lymphoma

Who this might be right for
Primary CNS Lymphoma
University College, London 12
Next Page